Triple
T20301166
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Lynparza |
E505481
|
entity |
| Predicate | associatedWithBiomarker |
P92924
|
FINISHED |
| Object | BRCA1 mutation |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: BRCA1 mutation | Statement: [Lynparza, associatedWithBiomarker, BRCA1 mutation]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: associatedWithBiomarker Context triple: [Lynparza, associatedWithBiomarker, BRCA1 mutation]
-
A.
usedAsBiomarkerFor
Indicates that one entity serves as a biomarker for another entity, typically signaling the presence, progression, or risk of a specific condition or biological state.
-
B.
diagnosticBiomarker
Indicates that one entity serves as a measurable biological indicator used to detect, confirm, or help diagnose a condition or disease in another entity.
-
C.
associatedWithPhenotype
Indicates that an entity has a documented connection or correlation with a particular phenotype or observable trait.
-
D.
hasPharmacogenomicAssociation
chosen
Indicates that there is a documented relationship between a genetic variant and a drug’s response, efficacy, or toxicity.
-
E.
associatedWithAntibody
Indicates a relationship where something is linked or connected to a specific antibody, such as being produced by it, targeted by it, or otherwise functionally related to it.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e0b4b8ab648190906e18538c250148 |
completed | April 16, 2026, 10:06 a.m. |
| NER | Named-entity recognition | batch_69e6770c700c81909da247cef0d0f1eb |
completed | April 20, 2026, 6:57 p.m. |
| PD | Predicate disambiguation | batch_69e55b21b09081909e46691b6f45a07f |
completed | April 19, 2026, 10:45 p.m. |
Created at: April 16, 2026, 11:17 a.m.